共 50 条
- [23] A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 358e1 - 358e7
- [28] Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 679 - 689